Cite
Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India.
MLA
Resendiz-Galvan, Juan Eduardo, et al. “Pharmacokinetic Analysis of Linezolid for Multidrug Resistant Tuberculosis at a Tertiary Care Centre in Mumbai, India.” Frontiers in Pharmacology, vol. 13, Jan. 2023, pp. 01-10. EBSCOhost, https://doi.org/10.3389/fphar.2022.1081123.
APA
Resendiz-Galvan, J. E., Arora, P. R., Abdelwahab, M. T., Udwadia, Z. F., Rodrigues, C., Gupta, A., Denti, P., Ashavaid, T. F., & Tornheim, J. A. (2023). Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India. Frontiers in Pharmacology, 13, 01-10. https://doi.org/10.3389/fphar.2022.1081123
Chicago
Resendiz-Galvan, Juan Eduardo, Prerna R. Arora, Mahmoud Tareq Abdelwahab, Zarir F. Udwadia, Camilla Rodrigues, Amita Gupta, Paolo Denti, Tester F. Ashavaid, and Jeffrey A. Tornheim. 2023. “Pharmacokinetic Analysis of Linezolid for Multidrug Resistant Tuberculosis at a Tertiary Care Centre in Mumbai, India.” Frontiers in Pharmacology 13 (January): 01-10. doi:10.3389/fphar.2022.1081123.